Overview

Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

Status:
Completed
Trial end date:
2018-10-29
Target enrollment:
Participant gender:
Summary
The purpose of this study will also assess the safety and tolerability of ANB020 in adult patients with severe eosinophilic asthma.
Phase:
Phase 2
Details
Lead Sponsor:
AnaptysBio, Inc.